Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Nuclear import receptors, also called importins, mediate nuclear import of proteins and chaperone aggregation-prone cargoes (e.g., neurodegeneration-linked RNA-binding proteins [RBPs]) in the cytoplasm. Importins were identified as modulators of cellular toxicity elicited by arginine-rich dipeptide repeat proteins (DPRs), an aberrant protein species found in C9orf72-linked amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Mechanistically, the link between importins and arginine-rich DPRs remains unclear. Here, we show that arginine-rich DPRs (poly-GR and poly-PR) bind directly to multiple importins and, in excess, promote their insolubility and condensation. In cells, poly-GR impairs Impα/β-mediated nuclear import, including import of TDP-43, an RBP that aggregates in C9orf72-ALS/FTD patients. Arginine-rich DPRs promote phase separation and insolubility of TDP-43 in vitro and in cells, and this pathological interaction is suppressed by elevating importin concentrations. Our findings suggest that importins can decrease toxicity of arginine-rich DPRs by suppressing their pathological interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 2×
“This hypothesis obtained strong support in recent years, when multiple groups studied the pathomechanism of the most frequent genetic cause of ALS and FTD, a large hexanucleotide repeat expansion in the C9orf72 gene (DeJesus-Hernandez et al., 2011; Renton et al., 2011), and identified compelling links to both the nucl…”
BackgroundA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“RBP pathology is thought to cause neuronal dysfunction and neurodegeneration through a combination of nuclear loss-of-function and cytoplasmic gain-of-function mechanisms (Ling et al., 2013).”
BackgroundSelf-citationThe C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982 · cited 26×
“Reduced importin levels during physiological aging could have direct implications for neurodegeneration in C9-ALS/FTD. Reduced importin levels could shift the DPR-importin ratio in a way that reduces the availability of import receptors, thereby promoting insolubility of certain RBPs and abrogating the chaperoning of…”
BackgroundInfluentialGGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., et al. (2015) · Nature · doi:10.1038/nature14974 · Cited by 841 · cited 5×
“Enhanced LLPS of RBPs, such as hnRNP-A1, TIA-1, and NPM1, by poly-GR and/or poly-PR has been previously reported (Boeynaems et al., 2017; Lee et al., 2016; Odeh and Shorter, 2020; White et al., 2019), but most of these RBPs have not been linked to C9-ALS/FTD.”
BackgroundInfluentialALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import
Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R. A., Capell, A., Schmid, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.143 · Cited by 836
Self-citationMertens, J., Paquola, A. C. M., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., McGrath, S., Campbell, B., Lee, H., Herdy, J. R., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.001 · Cited by 765 · cited 4×
“This finding raises the possibility that a decrease in the endogenous concentration of importins, which may arise during physiological aging (Mertens et al., 2015; Nishimura et al., 2010; Pujol et al., 2002), could contribute to the pathogenesis of C9-ALS/FTD, and suggests that importins are…”
BackgroundInfluentialC9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598 · cited 30×
“Reduced importin levels during physiological aging could have direct implications for neurodegeneration in C9-ALS/FTD. Reduced importin levels could shift the DPR-importin ratio in a way that reduces the availability of import receptors, thereby promoting insolubility of certain RBPs and abrogating the chaperoning of…”
InfluentialDipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1181-y · Cited by 345 · cited 2×
“However, it should be noted that the correlation of DPR inclusions in general with either neurodegeneration or TDP-43 pathology is still controversial and requires further investigation (Mackenzie et al., 2013, 2015; Mann et al., 2013; Saberi et al., 2018; Sakae et al., 2018; Schludi et al., 2015).”
BackgroundSelf-citation
Cited by
Types of nuclear localization signals and mechanisms of protein import into the nucleus
Lu, J., Wu, T., Zhang, B., Liu, S., Song, W., Qiao, J., & Ruan, H. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00741-y · Cited by 459
FUS and TDP-43 Phases in Health and Disease
Portz, B., Lee, B. L., & Shorter, J. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.12.005 · Cited by 327
Self-citationDisease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Gruijs da Silva, L. A., Simonetti, F., Hutten, S., Riemenschneider, H., Sternburg, E. L., Pietrek, L. M., Gebel, J., Dötsch, V., Edbauer, D., Hummer, G., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108443 · Cited by 192
Self-citationNuclear speckle proteins form intrinsic and MALAT1-dependent microphases
Shinn, M. K., Tomares, D. T., Liu, V., Pant, A., Qiu, Y., Vitalis, A., Song, Y. J., Ayala, Y., Ruff, K. M., Strout, G. W., et al. (2026) · Cell · doi:10.1016/j.cell.2025.11.026 · Cited by 38
C9orf72 polyPR directly binds to various nuclear transport components
Jafarinia, H., Van der Giessen, E., & Onck, P. R. (2023) · doi:10.1101/2023.06.22.546068 · Cited by 1
C9orf72 polyPR directly binds to various nuclear transport components
Jafarinia, H., Van der Giessen, E., & Onck, P. R. (2023) · doi:10.7554/elife.89694.2
Metadata
- Authors
- Hutten, S., Usluer, S., Bourgeois, B., Simonetti, F., Odeh, H. M., Fare, C. M., Czuppa, M., Hruska-Plochan, M., Hofweber, M., Polymenidou, M., Shorter, J., Edbauer, D., Madl, T., & Dormann, D.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 33
- Issue
- 12
- Pages
- 108538
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W3117521083
- Cited by
- 117
- References
- 15
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.